Biosimilars Guidance, Drugmaker Grades Coming, FDA Says

By Jeff Overley (October 2, 2013, 8:52 PM EDT) -- Biosimilars guidance will be out within one year, a Consumer Reports-style scorecard may soon describe drug manufacturing quality and companies shouldn't despair if regulators decline requests to meet about product development, staffers from the U.S. Food and Drug Administration said this week at a major conference in Boston....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!